Treatment for Cushing's in Dogs: Managing Canine...

If your dog has been drinking excessively, urinating more frequently, losing hair in symmetrical patches, or developing a pot-bellied appearance, you may be facing a diagnosis of Cushing's disease — medically known as hyperadrenocorticism. Understanding the treatment for Cushing's in dogs starts with recognizing that this endocrine disorder occurs when the body produces too much cortisol, a stress hormone normally released by the adrenal glands. Approximately 1 to 2 out of every 1,000 dogs develop Cushing's disease each year, with the condition most commonly affecting middle-aged to older dogs between 7 and 12 years of age. About 80-85% of cases are pituitary-dependent (PDH), caused by a benign tumor on the pituitary gland, while 15-20% are adrenal-dependent (ADH), caused by a tumor on one of the adrenal glands. A third form, iatrogenic Cushing's, results from prolonged corticosteroid medication use.

What Is Cushing's Disease in Dogs?

Cushing's disease is a hormonal disorder where the adrenal glands overproduce cortisol. In a healthy dog, the hypothalamus signals the pituitary gland to release adrenocorticotropic hormone (ACTH), which then tells the adrenal glands to release cortisol. When this feedback loop breaks down — usually because of a pituitary microadenoma (a small, typically benign tumor less than 10mm) or an adrenal tumor — cortisol floods the system unchecked.

The three forms of canine Cushing's disease are:

• Pituitary-Dependent Hyperadrenocorticism (PDH): Accounts for 80-85% of cases. A pituitary tumor overproduces ACTH, stimulating both adrenal glands to enlarge and overproduce cortisol.
• Adrenal-Dependent Hyperadrenocorticism (ADH): Accounts for 15-20% of cases. A tumor on one adrenal gland autonomously produces cortisol. Approximately 50% of adrenal tumors are malignant (adenocarcinomas), while 50% are benign adenomas.
• Iatrogenic Cushing's: Caused by long-term administration of corticosteroid medications such as prednisone, dexamethasone, or methylprednisolone — commonly prescribed for allergies, autoimmune conditions, or inflammation.

Recognizing the Symptoms of Cushing's Disease

Cushing's disease is notoriously insidious because symptoms develop gradually over months or even years. Many owners initially attribute early signs to normal aging. The following checklist organizes symptoms by how they typically present as the disease progresses.

A less common but serious complication is a pituitary macrotumor (greater than 10mm), which occurs in approximately 10-20% of PDH cases. These larger tumors can press on the brain, causing neurological symptoms including disorientation, head pressing, vision changes, pacing, or seizures. According to the Merck Veterinary Manual, neurological signs warrant immediate veterinary evaluation.

Breeds and Risk Factors for Cushing's Disease

Certain breeds show statistically higher rates of Cushing's disease. The American Kennel Club and veterinary endocrinology literature identify the following breeds as having elevated predisposition:

• Poodles (Miniature and Standard) — among the highest-risk breeds
• Dachshunds — particularly Miniature Dachshunds
• Yorkshire Terriers
• German Shepherd Dogs
• Boston Terriers
• Boxers
• Beagles
• Bichon Frises
• Terrier breeds broadly (Australian, Cairn, Scottish, Staffordshire)

It is important to note that any breed or mixed-breed dog can develop Cushing's disease. Breed predisposition indicates higher statistical likelihood, not certainty.

How Veterinarians Diagnose Cushing's Disease

Diagnosing Cushing's disease is one of the more complex endocrine workups in veterinary medicine because no single test provides a definitive answer in every case. Your veterinarian will typically follow a staged diagnostic process, starting with screening and progressing to confirmation and differentiation.

Stage 1: Initial Screening and Suspicion

Your vet will begin with a thorough physical exam, complete blood count (CBC), serum biochemistry panel, and urinalysis. Common findings that raise suspicion include elevated alkaline phosphatase (ALP), elevated cholesterol, diluted urine (low specific gravity), and stress leukogram patterns. These findings alone do not confirm Cushing's but justify further testing.

Stage 2: Confirmatory Endocrine Testing

Two primary screening tests are used to confirm hyperadrenocorticism:

1. Low-Dose Dexamethasone Suppression Test (LDDST): Blood is drawn before and at 4 and 8 hours after a small dose of dexamethasone is administered intravenously. In a healthy dog, dexamethasone suppresses cortisol production. In a dog with Cushing's, cortisol remains elevated. This test has a sensitivity of approximately 85-95% for PDH but may miss some mild cases. It also helps differentiate PDH from ADH based on the 4-hour cortisol level. Cost: $200-$350.
2. ACTH Stimulation Test: Measures cortisol before and 1-2 hours after synthetic ACTH injection. An exaggerated cortisol response suggests Cushing's. Sensitivity is approximately 80-85% for PDH and 60-75% for ADH, meaning some cases can be missed. This test is also essential for monitoring treatment response. Cost: $150-$300 (synthetic ACTH supply costs have risen significantly in recent years).

Stage 3: Differentiating PDH from ADH

Once Cushing's is confirmed, determining the type is critical for treatment planning:

• High-Dose Dexamethasone Suppression Test (HDDST): A higher dose of dexamethasone suppresses cortisol in about 60-70% of PDH cases but not in ADH. Cost: $150-$250.
• Endogenous ACTH Concentration: Blood measurement of the dog's own ACTH levels — elevated in PDH, low or undetectable in ADH. Requires special sample handling (frozen plasma shipped to a reference lab). Cost: $100-$200.
• Abdominal Ultrasound: Visualizes the adrenal glands. In PDH, both glands are typically normal or bilaterally enlarged. In ADH, one gland has a mass while the other is atrophied (shrunken). Also screens for tumor invasion into nearby blood vessels. Cost: $300-$600.
• CT or MRI of the Brain: Recommended when neurological symptoms suggest a pituitary macrotumor or when surgical planning for adrenalectomy requires detailed imaging. CT cost: $800-$1,500; MRI cost: $1,200-$2,500.

Treatment Options for Cushing's Disease in Dogs

The appropriate treatment for Cushing's in dogs depends on the type (PDH vs. ADH), tumor size, the dog's overall health, owner preferences, and budget. Below is a comparison of the primary treatment pathways.

Trilostane (Vetoryl®): The Current Standard of Care

Trilostane has largely replaced mitotane as the first-line medical treatment for Cushing's in dogs since receiving FDA approval for veterinary use. It is administered orally, typically once daily with food (some dogs require twice-daily dosing for adequate 24-hour cortisol control). Clinical improvement — reduced thirst, urination, and appetite — is usually noticeable within 1 to 4 weeks. Hair regrowth may take 3 to 6 months.

Monitoring protocol: An ACTH stimulation test is performed at 10-14 days after starting trilostane, again at 30 days, 90 days, and then every 3-6 months for the dog's lifetime. Your vet will also check electrolytes (sodium and potassium) at each monitoring visit because trilostane can occasionally cause an Addisonian crisis (adrenal insufficiency) — a potentially life-threatening complication characterized by sudden vomiting, diarrhea, collapse, and dangerously low sodium. If this occurs, trilostane is discontinued immediately and supportive treatment with IV fluids and sometimes glucocorticoids is administered.

Trilostane cost by dog size (monthly estimates, 2026 pricing):

• Small dogs (under 20 lb / 9 kg): $50-$80/month (30mg capsules)
• Medium dogs (20-50 lb / 9-23 kg): $80-$120/month (60mg capsules)
• Large dogs (50-100 lb / 23-45 kg): $120-$180/month (120mg capsules)
• Giant breeds (over 100 lb / 45 kg): $150-$250+/month (multiple capsules or compounded formulations)

Mitotane (Lysodren®): The Older Alternative

Mitotane works by chemically ablating the cortisol-producing layers of the adrenal cortex. Treatment begins with a daily "induction phase" lasting 5-10 days, during which the owner monitors for signs of adequate response: reduced appetite and water intake. If the dog shows these signs — or develops vomiting, diarrhea, or lethargy — induction stops and maintenance dosing begins (typically 1-2 times per week). While less expensive than trilostane, mitotane carries a higher risk of permanent hypoadrenocorticism (Addison's disease) if over-treated, and handling the tablets requires gloves since mitotane is a cytotoxic drug.

Prognosis and Life Expectancy

Many owners want to know: what is the life expectancy of a dog with Cushing's disease? The prognosis varies significantly depending on the type, tumor behavior, and how well the condition is managed.

Most dogs with pituitary-dependent Cushing's who receive consistent treatment and monitoring die with the disease rather than from it — meaning they typically succumb to unrelated age-related conditions. According to studies published in the Journal of Veterinary Internal Medicine, approximately 20% of treated PDH dogs develop diabetes mellitus as a comorbidity, which complicates management but does not necessarily shorten survival when both conditions are controlled.

Home Care, Monitoring, and Daily Management

Managing Cushing's disease is a long-term commitment. Here is what daily and ongoing care looks like for a dog on medical treatment:

Daily Care Requirements

• Medication administration: Give trilostane or mitotane at the same time each day, always with food to improve absorption and reduce GI upset.
• Water access: Never restrict water intake. Excessive thirst will gradually decrease as cortisol normalizes, but cutting off water access risks dehydration and kidney stress.
• Appetite monitoring: A sudden decrease in appetite can signal over-treatment (Addisonian crisis). Report this to your vet immediately.
• Observe urination: Track frequency and volume. Persistent accidents or straining may indicate a secondary urinary tract infection — common in Cushingoid dogs due to immunosuppression and dilute urine.
• Skin checks: Monitor for new calcinosis cutis lesions, skin infections, or worsening hair loss. Secondary bacterial or yeast skin infections may require topical or systemic treatment.

Veterinary Monitoring Schedule

• 10-14 days post-treatment start: ACTH stimulation test + electrolytes
• 30 days: ACTH stimulation test + electrolytes + clinical assessment
• 90 days: Full bloodwork + ACTH stimulation + urinalysis
• Every 3-6 months thereafter: ACTH stimulation test + bloodwork for life
• Annual: Abdominal ultrasound to monitor adrenal gland size and screen for other abdominal pathology

Lifestyle Adjustments

Dogs with Cushing's disease benefit from moderate, consistent exercise tailored to their energy level. Avoid sudden increases in activity intensity, as muscle weakness and joint stress are common. If your dog has calcinosis cutis, minimize friction or pressure on affected skin areas. Dietary adjustments are not usually required, but feeding a high-quality, balanced diet with moderate fat content supports overall metabolic health. There is no evidence that specific supplements cure Cushing's disease — be cautious of products marketed as "natural Cushing's cures" or "adrenal support supplements," as these are not FDA-evaluated and may interact with prescribed medications.

When to See the Vet: Emergency Red Flags

The Full Cost of Treating Cushing's Disease

Budgeting for Cushing's treatment requires planning for both the initial diagnostic investment and ongoing lifetime management. Here is a realistic breakdown:

Typical first-year total cost: $2,000 – $5,000+ (diagnosis + medication + monitoring). Ongoing annual cost: $1,200 – $4,500 depending on dog size, medication dose, and monitoring frequency. Pet insurance can significantly offset these costs if the policy was purchased before the Cushing's diagnosis — most providers cover endocrine disorders, but pre-existing condition exclusions apply universally.

Prevention: What You Can and Cannot Control

There is no proven way to prevent pituitary-dependent or adrenal-dependent Cushing's disease — these arise from spontaneous tumors with no established environmental cause. However, you can reduce risk where possible:

• Minimize unnecessary corticosteroid use: Work with your veterinarian to explore steroid-sparing alternatives for chronic conditions like allergies (e.g., oclacitinib/Apoquel®, lokivetmab/Cytopoint®, allergen-specific immunotherapy). If steroids are necessary, use the lowest effective dose for the shortest duration.
• Maintain routine veterinary care: Annual or biannual wellness exams with bloodwork can catch early metabolic changes before clinical signs become obvious — especially important for breeds at higher risk.
• Monitor for early symptoms: Tracking your dog's daily water intake can serve as an early detection tool. A sudden increase from, for example, 2 cups to 5 cups per day warrants a vet visit even before other symptoms appear.
• Choose responsible breeders: While no genetic test exists for Cushing's predisposition, responsible breeders who health-test their breeding stock and track lineage health data help reduce overall disease prevalence in breeds at risk.

Frequently Asked Questions About Cushing's Treatment

Can Cushing's disease in dogs be cured?

In most cases, Cushing's disease is managed rather than cured. Pituitary-dependent Cushing's requires lifelong medication and monitoring. Adrenal-dependent Cushing's caused by a benign adenoma can be cured through surgical removal of the affected adrenal gland, provided the dog survives the perioperative period. Malignant adrenal tumors have a guarded prognosis due to metastatic potential. Iatrogenic Cushing's is reversible by gradually tapering the causative corticosteroid under veterinary supervision.

How long does it take for Cushing's treatment to work?

With trilostane, most owners notice reduced drinking and urination within 1 to 4 weeks. Appetite normalization typically follows within 2 to 6 weeks. Hair regrowth and skin changes take longer — often 3 to 6 months — and some dogs never fully recover their original coat. ACTH stimulation test results at the 10-14 day check will confirm whether the dose is appropriate.

What happens if Cushing's disease is left untreated?

Untreated Cushing's disease progressively worsens. Chronic cortisol excess leads to severe muscle wasting, recurrent infections (skin, urinary, respiratory), hypertension, diabetes mellitus, pancreatitis, and pulmonary thromboembolism (blood clots in the lungs). Quality of life deteriorates significantly. Dogs with untreated Cushing's face a median survival of approximately 1 year from symptom onset, though some may survive longer with significant morbidity. Treatment substantially improves both comfort and longevity.

Is there a natural or holistic treatment for Cushing's in dogs?

No supplement, herb, or alternative therapy has been scientifically demonstrated to effectively treat Cushing's disease in dogs. Products marketed as "natural adrenal support" — including melatonin, lignans (flaxseed or HMR), ashwagandha, or phosphatidylserine — lack robust clinical evidence for efficacy in canine hyperadrenocorticism. While melatonin and lignans may have mild cortisol-modulating effects in laboratory settings, they do not replace the proven efficacy of trilostane or mitotane. Discuss any supplement use with your veterinarian, as some can interact with prescribed medications or mask monitoring test results.

Will my dog need to be on medication forever?

For pituitary-dependent Cushing's managed medically: yes, trilostane or mitotane is typically a lifelong commitment. Stopping the medication allows cortisol levels to rise again and symptoms to return, usually within days to weeks. The one exception is if hypophysectomy is performed at a specialty center and is successful — in that case, some dogs achieve long-term remission without medication, though ongoing monitoring is still necessary because recurrence can happen.

Managing Cushing's disease requires a committed partnership between you and your veterinary team. While the diagnosis can feel overwhelming — especially when considering the costs and lifelong monitoring involved — the vast majority of treated dogs experience significant improvement in quality of life and can enjoy years of comfortable living with their families.